Salivio Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 04-01-2025
- Paid Up Capital ₹ 1.00 M
as on 04-01-2025
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 141.35%
(FY 2022)
- Profit 113.03%
(FY 2022)
- Ebitda 251.89%
(FY 2022)
- Net Worth 1.67%
(FY 2022)
- Total Assets 23.87%
(FY 2022)
About Salivio Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sushil Singh, Manas Singh, and Arushi Singh serve as directors at the Company.
- CIN/LLPIN
U24304UR2016PTC007422
- Company No.
007422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2016
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Salivio Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manas Singh  | Director | 14-Feb-2017 | Current |
| Sushil Singh | Director | 25-Nov-2016 | Current |
| Arushi Singh | Director | 10-Dec-2022 | Current |
Financial Performance of Salivio Pharma.
Salivio Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 141.35% increase. The company also saw a substantial improvement in profitability, with a 113.03% increase in profit. The company's net worth moved up by a moderate rise of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salivio Pharma?
In 2017, Salivio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salivio Pharma?
Unlock and access historical data on people associated with Salivio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salivio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salivio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
